These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 17547497

  • 1. Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?
    Chambers HF, Hegde SS.
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):333-5. PubMed ID: 17547497
    [No Abstract] [Full Text] [Related]

  • 2. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
    Jørgen B, Merckoll P, Melby KK.
    Scand J Infect Dis; 2007 Jun; 39(11-12):1059-62. PubMed ID: 17852934
    [Abstract] [Full Text] [Related]

  • 3. Optimizing therapy for MRSA pneumonia.
    Skrupky LP, Micek ST, Kollef MH.
    Semin Respir Crit Care Med; 2007 Dec; 28(6):615-23. PubMed ID: 18095225
    [Abstract] [Full Text] [Related]

  • 4. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm.
    Raad I, Hanna H, Jiang Y, Dvorak T, Reitzel R, Chaiban G, Sherertz R, Hachem R.
    Antimicrob Agents Chemother; 2007 May; 51(5):1656-60. PubMed ID: 17353249
    [Abstract] [Full Text] [Related]

  • 5. Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
    Shams W, Walker ES, Levy F, Reynolds SA, Peterson SM, Sarubbi FA.
    Chemotherapy; 2010 May; 56(5):411-6. PubMed ID: 20948212
    [Abstract] [Full Text] [Related]

  • 6. Optimizing therapy for methicillin-resistant Staphylococcus aureus bacteremia.
    Cosgrove SE, Fowler VG.
    Semin Respir Crit Care Med; 2007 Dec; 28(6):624-31. PubMed ID: 18095226
    [Abstract] [Full Text] [Related]

  • 7. Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics.
    Samra Z, Ofer O, Shmuely H.
    Isr Med Assoc J; 2005 Mar; 7(3):148-50. PubMed ID: 15792257
    [Abstract] [Full Text] [Related]

  • 8. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD, Gelfand MS, Cleveland KO, Usery JB.
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group.
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [Abstract] [Full Text] [Related]

  • 10. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.
    Huang YT, Liao CH, Teng LJ, Hsueh PR.
    Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671
    [Abstract] [Full Text] [Related]

  • 11. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW, Murray CK, Holmes RL, Patterson JE, Jorgensen JH.
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [Abstract] [Full Text] [Related]

  • 12. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G, White R, Friedrich L.
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [Abstract] [Full Text] [Related]

  • 13. Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
    Salem AH, Zhanel GG, Ibrahim SA, Noreddin AM.
    Clin Exp Pharmacol Physiol; 2014 Jun; 41(6):437-43. PubMed ID: 24341387
    [Abstract] [Full Text] [Related]

  • 14. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 15. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR.
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.
    Anastasiou DM, Thorne GM, Luperchio SA, Alder JD.
    Int J Antimicrob Agents; 2006 Nov; 28(5):385-8. PubMed ID: 17046205
    [Abstract] [Full Text] [Related]

  • 17. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
    Abb J.
    Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
    [No Abstract] [Full Text] [Related]

  • 18. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C, Caillon J, Le Mabecque V, Miègeville AF, Hamel A, Bugnon D, Ge JY, Potel G.
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [Abstract] [Full Text] [Related]

  • 19. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.
    Clin Infect Dis; 2009 Oct 15; 49(8):1169-74. PubMed ID: 19769538
    [Abstract] [Full Text] [Related]

  • 20. Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.
    Cha R, Brown WJ, Rybak MJ.
    Antimicrob Agents Chemother; 2003 Dec 15; 47(12):3960-3. PubMed ID: 14638509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.